Announcement on the Subsidiary Company Obtaining the Pharmaceutical Production License
Release time:
2021-05-20
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: 2019-037
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Subsidiary Obtaining Drug Production License
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Recently, Anhui Zhongwang Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui Zhongwang"), a subsidiary of Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the Company"), received the "Drug Production License" issued by Anhui Drug Administration. The relevant information is hereby announced as follows:
1. Certificate Related Information
(I) Enterprise Name: anhui Zhongwang Pharmaceutical Co., Ltd.
(II) Registered Address: Anhui Dongzhe Economic Development Zone
(III) License No.: Anhui 20190419
(IV) Production Address: Anhui Dongzhe Economic Development Zone
(V) Production Scope: API
(VI) Issuing Authority: Anhui Drug Administration
(VII) Valid: 2020 12 31
2. Impact on Listed Companies and Risk Tips
This "Drug Production License" expands the scope of Anhui Zhongwang's production license, lays a foundation for Anhui Zhongwang's future production of bulk drugs, and is conducive to promoting the company's pharmaceutical industry to gradually implement the strategic upgrading of the whole industrial chain of intermediates, bulk drugs and preparations. After Anhui Zhongwang obtained the "Drug Production License" this time, it still needs to conduct the review and approval of the API, and obtain the relevant API registration number before production and sales can be carried out. The acquisition of the Pharmaceutical Production License will not have a significant impact on the Company's current operations.
Due to the industry characteristics of pharmaceutical products, the production and sales of pharmaceuticals are affected by factors such as market environment, industry policies, supply and demand, and have certain uncertainties. Please the majority of investors cautious decision-making, pay attention to prevent investment risk.
hereby announces
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
November 27, 2019
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08